A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects

Inclusion Criteria: * Intra-abdominal infection requiring surgery and Intensive Care Unit stay * If Community Acquired Intra-Abdominal Infection, at least 72 hours (but not more than 120 hours) of Intensive Care Unit stay, counted from the end of surgery, and a further expected duration of Intensive Care Unit stay of ≥ 48 hours * If Nosocomial Intra-Abdominal Infection, duration of Intensive Care Unit stay ≤ 48 hours, counted from the end of surgery, and a further expected duration of Intensive Care Unit stay of ≥ 48 hours * Female subject of childbearing potential must have a negative urine or serum pregnancy test prior to randomization and must agree to maintain highly effective birth control during the study Exclusion Criteria: * Acute pancreatitis * Neutropenia (ANC \<1,000/mm3) at the time of randomization * Infected intra-peritoneal dialysis * Patients undergoing solid organ transplantation * Documented invasive candidiasis at the time of randomization * Expected survival \< 48 hours * Any systemically active anti-fungal within 14 days prior to administration of the study drug * Allergy, hypersensitivity, or any serious reaction to an echinocandin anti-fungal or any of the study drug excipients * Currently receiving and/or has taken an investigational drug within 28 days prior to randomization * Pregnant woman or breast-feeding mother * 'Do Not Resuscitate' order